Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer

Clinical trial NCT07538193 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07538193
Sponsor: Tang-Du Hospital
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung (NSCLC)Neoplasm Staging Lymphatic Metastasis

Start date: 2026-05-01
Primary completion: 2029-05-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.